Our CEO will give a pitch and a poster presentation at TOKYO SUTEAM Startup Crossroads Tokyo.

TOKYO SUTEAM, an organization that supports entrepreneurs, supporters, researchers, and investors in the fields of life science, deep tech, biotechnology, and healthcare, will jointly hold a networking event “Startup Crossroads Tokyo”. As a company selected for the “Rising Biotech Challenge” by Plug and Play Japan, a partner of TOKYO SUTEAM, our CEO, Shin Yoshida, will give a short pitch and display a poster. Event Information Date & Time: Monday, August 4, 2025 17:00-20:00 (our presentation will be from 18:05-18:30) Location: Nihonbashi Life Science Hub (8th Floor) Get more information: https://www.link-j.org/event/article-47431.html

Presentation at Drug Discovery Modality Study Group of JBA

We will be giving a pitch presentation at JBA (Japan Bioindustry Association) Drug Discovery Modality Study Group.

The theme of the 7th General Assembly is "Development of Drug Discovery through Innovation and Combination of Technologies".

Event Overview

Date and Time: Friday, July 18, 2025, 14:30–17:00*

*Our pitch presentation: 16:00-16:40

Venue: Hybrid of Online (Zoom) and Onsite (JBA Office)

Organizer: Japan Bioindustry Association (JBA), Drug Discovery Modality Study Group "Biomaterials Protective Hydrogels Support Drug Discovery Modality" We have developed zwitterionic hydrogel technology for long-term stabilization of biomaterials such as enzymes, nucleic acids, and proteins. This presentation will introduce the hydrogel technology that dramatically improves the storage stability, blood retention, and reaction efficiency of biopharmaceuticals with the successful examples.

Exhibit at BIO2025/Japan Pavilion

Gel Coat Biomaterials exhibited at the BIO International Convention 2025 (BIO2025),one of the largest global biotechnology exhibitions in Boston this year from June 16 to 19.

BIO2025 attracted many visitors, and they visited our booth at Japan Pavilion as well with great interest.

Many global companies and research institutions expressed interest in our hydrogel technologies, and we were able to discuss future collaborations.